Literature DB >> 17620887

Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence.

Luke Molloy1.   

Abstract

(1) Sialorrhoea is a common condition in patients with Parkinson's disease that has a negative impact on patient quality of life. (2) Traditionally, muscarinic antagonists have been the pharmacological agents of choice for the treatment of sialorrhoea; however, these agents are frequently associated with adverse events in patients with Parkinsonian disorders. (3) Recent studies suggest that botulinum toxin injection is currently the most effective treatment option for Parkinsonian-related sialorrhoea.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17620887     DOI： 10.1097/01.wco.0000280411.57836.aa

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN： 1350-7540            Impact factor:   5.710


  6 in total

Review 1.  The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease.

Authors:  Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2015-07-03       Impact factor: 3.575

Review 2.  [Nonmotor symptoms in Parkinson's disease].

Authors:  W H Jost
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

3.  Effects of Repeated Botulinum Toxin Treatment for Sialorrhea in Patients with Parkinson's Disease.

Authors:  Aysu Şen; Baki Arpaci
Journal:  Noro Psikiyatr Ars       Date:  2015-03-01       Impact factor: 1.339

Review 4.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

Review 5.  Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.

Authors:  Marcelo Merello
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Radiation of parotid or submandibular glands is effective for drooling in patients with parkinsonism; a randomised double-blind placebo-controlled trial.

Authors:  R J H M Steenbakkers; S P van Doornik; A Vissink; W Kerdijk; T van Laar
Journal:  Clin Park Relat Disord       Date:  2022-02-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.